One of the biggest companies in the nuclear energy industry recently announced a seismic shift that could help cement its position as a strong leader in the space. Cameco Corp. (NYSE: CCJ) announced on July 31 that Westinghouse Electric—jointly owned by Cameco and Brookfield Renewable Partners (NYSE: BEP)—confidentially filed a draft registration statement in a critical move toward a potential IPO.
Cameco and Brookfield acquired Westinghouse not even three years ago, and Cameco took on significant debt to finance the deal—the company now has the opportunity to raise capital, pay down its debt, and support its valuation in a way that could signal strength across the nuclear energy industry. What's more, the benefits could extend beyond these companies, as the move could help enhance the viability of nuclear energy as an investment thesis more broadly. NuScale Power (NYSE: SMR) and Fluor Corp. (NYSE: FLR) occupy different niches than Cameco—as a small modular reactor developer and an engineering firm, respectively—allowing them to distinguish themselves as the industry shifts.
Cameco's Buy Opportunity Comes at the Right Time
Shares of Cameco have experienced plenty of volatility this year; even though the stock is up more than 7% year to date (YTD), it still trades roughly 27% below its January high. While analysts are still broadly bullish, there’s a case to be made that Cameco is in buy-the-dip territory.
This comes at a great time alongside the company's announcement of Westinghouse's move toward an IPO. After Cameco bought up a 49% stake in Westinghouse three years ago, it has locked in commitments to deliver about 28 million pounds of uranium annually through 2030—a tremendous feat of demand, to be sure, but one that is difficult for the company to sustain given its debt load. The Westinghouse stake has also limited Cameco's quarterly financial performance, with the firm reporting Q2 and H1 2026 results below the prior-year periods due to payments tied to the smaller company.
With production guidance remaining strong and overall market conditions improving, Cameco would be well-positioned to benefit from the additional financial flexibility that a Westinghouse IPO would provide, potentially enabling it to sell equity to fund acquisitions, future partnerships, or capacity expansion.
NuScale's Quarterly Revenue Plunge May Be a Unique Aberration
An IPO for Westinghouse has the capacity to benefit the broader nuclear energy industry, thanks to its vote of confidence in the space. Alongside rising electricity demand among data centers, companies with a niche focus may be uniquely advantaged in this scenario. This includes NuScale Power, which is known for building small modular reactors (SMRs) with lower upfront costs and greater deployment flexibility.
Westinghouse is unlikely to be a direct competitor to NuScale, as the former company focuses on larger reactors, but a strong valuation at the time of an IPO could signal that emerging nuclear companies like NuScale are worth a closer look. NuScale is valued at about $3.5 billion, a fraction of Cameco, and shares are down almost 32% YTD.
The company desperately needs a commercial win after its Q2 2026 revenue declined to almost nil, although management attributed the performance to a one-time adjustment. Still, with close to $2 billion in cash on hand and a critical position as the only SMR developer with key design certification, NuScale appears ready for a catalyst to move it toward profitability.
Fluor Has Confidence in Its Shares, But Analysts Are Not Yet in Agreement
Fluor is an engineering and construction firm that designs and builds large-scale nuclear energy infrastructure—it is also a major contractor for NuScale's RoPower project in Romania. Fluor sold its NuScale stake for more than $1.3 billion in February 2026, freeing up the company to buy back a sizable portion of its own shares. FLR stock has had a very different pathway from SMR so far in 2026, rising by about 34% YTD.
This may be due to the company's financial results, which have also trended very differently. Fluor improved revenue by almost 9% year over year (YOY) and posted a solid earnings beat in Q2 2026 as it built its backlog to nearly $27 billion and generated $6 billion in new awards. Adjusted EBITDA is improving, and the firm is also building its operating cash flow.
Critics may counter that this backlog and Fluor's reimbursable contracts are not necessarily a sign of stable earnings growth, alongside some analyst hesitation (FLR shares are currently rated Hold overall). This may be all the more reason an industry-wide shift in institutional interest, driven by the Westinghouse IPO, could help boost Fluor's prospects.
The article "A Westinghouse IPO Could Reset the Nuclear Stock Conversation" first appeared on MarketBeat.
